Maintenance therapy and advanced non-small-cell lung cancer: A skeptic's view

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Maintenance Therapy 100%
• Overall Survival 50%
• Survival 50%
• Inpatient 50%
• Quality of Life 50%
• Platinum 50%
• Pemetrexed 50%
• Erlotinib 50%
• Hematologic Malignancy 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Chemotherapy 100%
• Survival 50%
• Platinum 50%
• Overall Survival 50%
• Erlotinib 50%
• Pemetrexed 50%
• Hematologic Malignancy 50%